Desmoid Tumors and Celecoxib with Sorafenib

Overview of attention for article published in New England Journal of Medicine, June 2017

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (90th percentile)

Mentioned by

news: 1 news outlet
twitter: 25 X users

facebook: 3 Facebook pages
googleplus: 1 Google+ user

Citations

dimensions_citation: 12 Dimensions

Readers on

mendeley: 16 Mendeley

Summary News X Facebook Google+ Dimensions citations

So far, Altmetric has seen 1 Google+ post.

Sun Young Kim, 14 Jun 2018

https://www.nejm.org/doi/full/10.1056/NEJMc1702562 celecoxib 400mg + sorafenib 600mg for desmoid tumor... https://www.nejm.org/do…

This page shows the most recent Google+ posts that mention this research output.

Click here to find out how to access more activity.